Delivery Order SPE2DB22D3011-SPE2DB24FP9NX
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a ceiling value of $6,906.06 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc....
- This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, for a ceiling value of $5,492.53. The contract has a completion date of February 29, 2024 and is a firm fixed-price contract. This order is part of Amerisourcebergen's significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,433.86, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The award has an ultimate completion date of January 12, 2024 and is a Firm Fixed Price Delivery Order contract. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the purchase of Advair HFA 45-21 MCG Inhaler 12GM. The contract has a ceiling value of $6,408.23 and a completion date of January 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $7,672.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM, a pharmaceutical product, with a period of performance ending on January 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product, with a ceiling value of $1,155.22 and a performance period through April 9, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is an experienced provider of...
- This federal contract award, valued at $3,282.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 115-21 MCG inhalers, a prescription pharmaceutical product. The contract has a period of performance ending on February 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication. The firm-fixed price contract has a ceiling value of $36,100.95 and a performance period ending August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a critical respiratory medication, with a ceiling value of $9,878.65 and a performance period through August 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- The federal contract award, with ID SPE2DB20D3304|SPE2DB24FW5B2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,060.08 firm-fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9NXDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product, with a ceiling value of $6,065.63 and a period of performance ending on March 1, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 2/29/24 |